Sabina Semiz

1.9k total citations
42 papers, 1.0k citations indexed

About

Sabina Semiz is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Epidemiology. According to data from OpenAlex, Sabina Semiz has authored 42 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 12 papers in Endocrinology, Diabetes and Metabolism and 8 papers in Epidemiology. Recurrent topics in Sabina Semiz's work include Metabolism, Diabetes, and Cancer (8 papers), Liver Disease Diagnosis and Treatment (6 papers) and Pharmacogenetics and Drug Metabolism (5 papers). Sabina Semiz is often cited by papers focused on Metabolism, Diabetes, and Cancer (8 papers), Liver Disease Diagnosis and Treatment (6 papers) and Pharmacogenetics and Drug Metabolism (5 papers). Sabina Semiz collaborates with scholars based in Bosnia and Herzegovina, Slovenia and United Arab Emirates. Sabina Semiz's co-authors include Tanja Dujić, Tamer Bego, Maja Malenica, Adlija Čaušević, Besim Prnjavorac, John H. McNeill, Ewan R. Pearson, Zelija Velija-Ašimi, Janja Marc and Chris Orvig and has published in prestigious journals such as SHILAP Revista de lepidopterología, The EMBO Journal and Diabetes.

In The Last Decade

Sabina Semiz

39 papers receiving 1.0k citations

Peers

Sabina Semiz
Solomon S. Solomon United States
Stefan Schunk Germany
Francesca Franco Italy
Masami Nemoto Japan
Yin Cai China
Kunal K. Sindhu United States
Aihua Lu China
Mark J Magera United States
B. A. Rosner United States
Naoki Ashizawa Japan
Solomon S. Solomon United States
Sabina Semiz
Citations per year, relative to Sabina Semiz Sabina Semiz (= 1×) peers Solomon S. Solomon

Countries citing papers authored by Sabina Semiz

Since Specialization
Citations

This map shows the geographic impact of Sabina Semiz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sabina Semiz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sabina Semiz more than expected).

Fields of papers citing papers by Sabina Semiz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sabina Semiz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sabina Semiz. The network helps show where Sabina Semiz may publish in the future.

Co-authorship network of co-authors of Sabina Semiz

This figure shows the co-authorship network connecting the top 25 collaborators of Sabina Semiz. A scholar is included among the top collaborators of Sabina Semiz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sabina Semiz. Sabina Semiz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Serdarević, Fadila, et al.. (2025). Lifestyle habits and type 2 diabetes traits in patients from healthcare centers in Dubai, United Arab Emirates: a cross-sectional study. Frontiers in Endocrinology. 16. 1436536–1436536.
2.
Reljic, Tea, T.P. Smith, Fadila Serdarević, et al.. (2024). PPAR agonists as add-on treatment with metformin in management of type 2 diabetes: a systematic review and meta-analysis. Scientific Reports. 14(1). 8809–8809. 14 indexed citations
3.
Semiz, Sabina. (2022). COVID19 biomarkers: What did we learn from systematic reviews?. Frontiers in Cellular and Infection Microbiology. 12. 1038908–1038908. 28 indexed citations
4.
Semiz, Sabina. (2021). Vanadium as potential therapeutic agent for COVID-19: A focus on its antiviral, antiinflamatory, and antihyperglycemic effects. Journal of Trace Elements in Medicine and Biology. 69. 126887–126887. 34 indexed citations
5.
Semiz, Sabina. (2021). SIT1 transporter as a potential novel target in treatment of COVID-19. BioMolecular Concepts. 12(1). 156–163. 6 indexed citations
6.
Semiz, Sabina & Fadila Serdarević. (2020). Prevention and Management of Type 2 Diabetes and Metabolic Syndrome in the Time of COVID-19: Should We Add a Cup of Coffee?. Frontiers in Nutrition. 7. 581680–581680. 4 indexed citations
7.
Dujić, Tanja, Tamer Bego, Maja Malenica, et al.. (2019). Effects of TCF7L2 rs7903146 variant on metformin response in patients with type 2 diabetes. SHILAP Revista de lepidopterología. 19(4). 368–374. 11 indexed citations
8.
Bego, Tamer, Maria Sterner, Emma Ahlqvist, et al.. (2019). Association of IRS1 genetic variants with glucose control and insulin resistance in type 2 diabetic patients from Bosnia and Herzegovina. Drug Metabolism and Personalized Therapy. 34(1). 10 indexed citations
9.
Bego, Tamer, Adlija Čaušević, Tanja Dujić, et al.. (2018). Association of FTO gene variant (rs8050136) with type 2 diabetes and markers of obesity, glycaemic control and inflammation. Journal of Medical Biochemistry. 38(2). 153–163. 30 indexed citations
10.
Malenica, Maja, Besim Prnjavorac, Tamer Bego, et al.. (2017). Effect of Cigarette Smoking on Haematological Parameters in Healthy Population. Medical Archives. 71(2). 132–132. 138 indexed citations
11.
Liu, Jun, Sabina Semiz, Sven J. van der Lee, et al.. (2017). Metabolomics based markers predict type 2 diabetes in a 14-year follow-up study. Metabolomics. 13(9). 104–104. 63 indexed citations
12.
Malenica, Maja, Besim Prnjavorac, Adlija Čaušević, et al.. (2016). Use of Databases for Early Recognition of Risk of Diabetic Complication by Analysis of Liver Enzymes in Type 2 Diabetes Mellitus. Acta Informatica Medica. 24(2). 90–90. 7 indexed citations
13.
Bego, Tamer, Tanja Dujić, Barbara Mlinar, et al.. (2015). Association of LPIN1 gene variations with markers of metabolic syndrome in population from Bosnia and Herzegovina. Medicinski Glasnik. 13(2). 1 indexed citations
14.
Semiz, Sabina, Tanja Dujić, & Adlija Čaušević. (2013). Pharmacogenetics and personalized treatment of type 2 diabetes. Biochemia Medica. 23(2). 154–171. 39 indexed citations
15.
Semiz, Sabina, Tanja Dujić, Barbara Ostanek, et al.. (2011). Analysis of CYP3A4*1B and CYP3A5*3 polymorphisms in population of Bosnia and Herzegovina.. PubMed. 8(1). 84–9. 13 indexed citations
16.
Semiz, Sabina, Tanja Dujić, Barbara Ostanek, et al.. (2011). Association of NAT2 Polymorphisms with Type 2 Diabetes in a Population from Bosnia and Herzegovina. Archives of Medical Research. 42(4). 311–317. 11 indexed citations
17.
Semiz, Sabina, Tanja Dujić, Barbara Ostanek, et al.. (2010). Analysis of CYP2C9*2, CYP2C19*2, and CYP2D6*4 polymorphisms in patients with type 2 diabetes mellitus. SHILAP Revista de lepidopterología. 10(4). 287–291. 18 indexed citations
18.
Čaušević, Adlija, et al.. (2010). Relevance of Uric Acid in Progression of Type 2 Diabetes Mellitus. SHILAP Revista de lepidopterología. 10(1). 54–59. 29 indexed citations
19.
Zhou, Qiong, Zhen Jiang, John Holik, et al.. (2004). Analysis of insulin signalling by RNAi-based gene silencing. Biochemical Society Transactions. 32(5). 817–821. 68 indexed citations
20.
Semiz, Sabina & John H. McNeill. (2002). Oral treatment with vanadium of Zucker fatty rats activates muscle glycogen synthesis and insulin-stimulated protein phosphatase-1 activity. Molecular and Cellular Biochemistry. 236(1-2). 123–131. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Solomon S. Solomon Breakdown of academic impact, for papers by Stefan Schunk Breakdown of academic impact, for papers by Francesca Franco Breakdown of academic impact, for papers by Masami Nemoto Breakdown of academic impact, for papers by Yin Cai Breakdown of academic impact, for papers by Kunal K. Sindhu Breakdown of academic impact, for papers by Aihua Lu Breakdown of academic impact, for papers by Mark J Magera Breakdown of academic impact, for papers by B. A. Rosner Breakdown of academic impact, for papers by Naoki Ashizawa
Rankless by CCL
2026